Impact summary
This wide reaching Senate Inquiry investigated the historical use of two antimalarial drugs, mefloquine and tafenoquine, in the Australian Defence Force. Outcomes included recommendations to change the consent processes for Australian Defence Force members involved in clinical trials and the need for an outreach program for affected veterans and their families.Category of impact | Quality of life Impact, Social Impact |
---|
Keywords
- veteran
- Australian Defence Force
- Mefloquine
- tafenoquine
- drug trial
- neurocognitive health
Documents & Links
- Report - Senate Inquiry into use of mefloquine and tafenoquine in ADF
File: application/pdf, 1.07 MB
Type: Text
Related content
-
Impacts
-
Activities
-
Australian Quinoline Veterans and Families Association (QVFA) (External organisation)
Activity: Membership › Advisory position/panel/policy group/board › Community
-
Press/Media
-
https://thenewdaily.com.au/news/national/2018/11/05/veterans-anti-malarial-drug-trial-senate-inquiry/
Press/Media: Press / Media
-
Australian veterans renew call for Defence to acknowledge side effects of Larium
Press/Media: Press / Media
-
Research Outputs
-
Better approach needed to detect and treat military personnel with adverse effects from mefloquine
Research output: Contribution to journal › Article › peer-review
-
Complex membrane channel blockade: A unifying hypothesis for the prodromal and acute neuropsychiatric sequelae resulting from exposure to the antimalarial drug Mefloquine
Research output: Contribution to journal › Article › peer-review